Alto Neuroscience, Inc. (ANRO) Debt Components
- 2026-06-30: Long-term Debt, Current MaturitiesUSD $3.77M; Long-term Debt, Excluding Current MaturitiesUSD $12.42M; Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
- 2026-03-31: Long-term Debt, Current MaturitiesUSD $2.14M; Long-term Debt, Excluding Current MaturitiesUSD $13.88M; Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
- 2025-12-31: Long-term Debt, Current MaturitiesUSD $585.00K; Long-term Debt, Excluding Current MaturitiesUSD $16.17M; Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
- 2025-09-30: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD $20.31M; Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
Alto Neuroscience, Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Long-Term Debt, Maturity, Remainder of Fiscal Year USD | Long-term Debt, Gross USD | Debt Instrument, Basis Spread on Variable Rate pure | Debt Instrument, Unamortized Discount USD |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.77M | $12.42M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $2.14M | $13.88M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $585.00K | $16.17M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | $20.31M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | $20.12M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | $19.94M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $0.00 | $10.25M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | (m) | $10.25M | $4.77M | $5.23M | $0.00 | $0.00 | (m) | $10.00M | (m) | $105.00K |
| 2024-09-30 | $3.53M | $6.63M | $10.16M | $4.77M | $5.23M | (m) | (m) | $0.00 | $10.00M | (m) | $118.00K |
| 2024-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 1 month · 2.00% | (m) |
| 2024-06-30 | $2.32M | $7.74M | $10.06M | $4.77M | $5.23M | (m) | (m) | $0.00 | $10.00M | (m) | $131.00K |
| 2024-03-31 | $1.15M | $8.81M | $9.96M | $4.77M | $5.23M | (m) | (m) | $0.00 | $10.00M | (m) | $144.00K |
| 2023-12-31 | (m) | $9.86M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |